TSXV:MGRO - Post Discussion
Post by
lscfa on May 08, 2023 4:34pm
Fins on sedar
Payments from partners were not disclosed in NRs.....
Deferred revenue
In August 2022, the Company and Sumitomo Corporation extended their Exclusive Evaluation and Option Agreement. Pursuanttotheextensionagreement,MustGrowreceivedUSD500,000($641,200)whichhas been allocated to a future performance obligation and as such was recorded as deferred revenue.
In April 2022, the Company entered into an exclusive evaluation and option agreement with Janssen PMP, a division of Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical companies of Johnson and Johnson. Pursuant to the agreement, MustGrow received EUR 200,000 ($272,500) which has been allocated to a future performance obligation and as such was recorded as deferred revenue.
Be the first to comment on this post